Politico reports exclusively that HHS secretary Alex Azar ordered FDA to stop evaluating laboratory-developed tests over the objections of commissione...
FDA announces a 10/30 virtual public workshop on New Drugs Regulatory Program Modernization: Implementation of the Integrated Assessment of Marketing ...
SheppardMullin attorneys say FDA seems to be years away from implementing its pilot software pre-certification program.
FDA classifies as Class 1 a recall involving a Becton Dickinson CareFusion recall of its Alaris Syringe and Alaris PCA Modules due to potential incorr...
An updated CBER guidance agenda for 2020 lists 29 planned guidances in four categories.
FDA approves GE Healthcares shatterproof polymer +PLUSPAK Pharmacy Bulk Package for use with its macrocyclic gadolinium-based MRI contrast agent, Clar...
Three drug industry stakeholders give FDA feedback on its public meeting on an independent assessment of FDA-sponsor IND communications.
Axios/Ipsos poll respondents say they have little faith in FDA or the drug industry to be looking out for the publics interests.